Skip to main content
Nath Biogene India Ltd. logo

Nath Biogene India Ltd. — Investor Relations & Filings

Ticker · NATHBIOGEN ISIN · INE448G01010 BSE.NS Agriculture, forestry and fishing
Open in API
Filings indexed 450 across all filing types
Latest filing 2024-11-28 Regulatory Filings
Country IN India
Listing BSE.NS NATHBIOGEN

About Nath Biogene India Ltd.

https://www.nathbiogenes.com

Nath Biogene India Ltd. specializes in the research, development, production, and marketing of high-quality hybrid seeds. The company maintains a diverse product portfolio encompassing field crops such as cotton, paddy, maize, jowar, and bajra, alongside a wide range of vegetable seeds including tomato, okra, and chili. With a strong emphasis on biotechnological innovation and plant breeding, the organization focuses on developing high-yielding, pest-resistant, and climate-resilient seed varieties to enhance agricultural productivity. Its operations are supported by extensive research and development facilities and a robust distribution network that ensures the delivery of advanced genetic materials to farming communities. The company leverages its technical expertise to provide integrated solutions aimed at improving crop quality and farmer profitability through sustainable agricultural practices.

Recent filings

Filing Released Lang Actions
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) informing about the loss of a share certificate. It references Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, which pertains to share certificate loss reporting. The content is a notification about a specific administrative issue related to share certificates, not a financial report, earnings release, or management discussion. It does not contain financial data, audit information, or meeting materials. This type of document is a regulatory announcement related to compliance and disclosure obligations but does not fit into more specific categories like share issue or director dealings. Therefore, it best fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories. The document length is short and focused on a compliance notification, reinforcing this classification.
2024-11-28 English
Updates
Call Transcript Classification · 100% confidence The document is a transcript of a conference call held on October 24, 2024, discussing the company's unaudited financial results for the quarter and half year ended September 30, 2024. It includes detailed management commentary on financial performance, business outlook, product portfolio, and a Q&A session with analysts. The presence of a full transcript of the earnings call, including management presentations and Q&A, clearly identifies this as a Call Transcript (CT). The document is lengthy (15,000 characters) and contains substantive content, not just an announcement or summary, so it is not an Earnings Release (ER) or Report Publication Announcement (RPA).
2024-10-28 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a Compliance Certificate submitted under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September 2024. It is a formal attestation from the Registrar and Share Transfer Agent confirming dematerialization and listing compliance. The document is short (2860 characters) and serves as a regulatory compliance submission rather than a financial report or detailed analysis. It does not contain financial statements, management discussion, or audit information. It is primarily a regulatory filing to stock exchanges and SEBI. Therefore, it fits best under Regulatory Filings (RNS) as a compliance certificate submission.
2024-10-28 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the submission of an audio recording of a conference call. It references Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) and mentions the conference call was held to discuss unaudited financial results for the quarter and half year ended 30th September 2024. The document provides a link to the audio recording but does not contain the transcript or detailed financial data itself. The document length is short (1461 characters) and serves as an announcement of the availability of the conference call recording rather than the transcript or report itself. According to the classification rules, such a document is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement about the availability of the call recording, not the call transcript itself or a financial report.
2024-10-25 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the submission of an audio recording of a conference call. It references Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) and mentions the conference call held to discuss unaudited financial results for the quarter and half year ended 30th September 2024. The document provides a link to the audio recording but does not contain the transcript or detailed financial data itself. The document length is short (1461 characters) and serves as an announcement of the availability of the conference call recording rather than the transcript or detailed report. According to the classification rules, a document that announces or provides access to a conference call recording without the full transcript should be classified as Regulatory Filings (RNS), since it does not contain the full call transcript (CT) or substantive financial data (IR).
2024-10-25 English
Updates
Interim / Quarterly Report Classification · 95% confidence The document is titled as a presentation on unaudited financial results for the period ended 30th September 2024, which corresponds to the second quarter and half-year of fiscal year 2025 (Q2 & H1FY25). It contains detailed financial data including income statements, segmental revenue, balance sheets, and business highlights. The document is about 9,790 characters long, which is substantial and contains actual financial data and analysis, not just an announcement or a certification. The content is consistent with a comprehensive interim or quarterly financial report rather than a brief earnings release or an investor presentation. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2025
2024-10-23 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.